PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Stein, R. ; Koutny, F.* ; Riedel, J.* ; Doerr, N.* ; Meyer, K. ; Colombo, M.* ; Vogel, M.* ; Anderwald, C.H.* ; Blüher, M. ; Kiess, W.* ; Körner, A. ; Weghuber, D.*

Single point insulin sensitivity estimator (SPISE) as a prognostic marker for emerging dysglycemia in children with overweight or obesity.

Metabolites 13:12 (2023)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The single point insulin sensitivity estimator (SPISE) is a recently developed fasting index for insulin sensitivity based on triglycerides, high density lipoprotein cholesterol, and body mass index. SPISE has been validated in juveniles and adults; still, its role during childhood remains unclear. To evaluate the age- and sex-specific distribution of SPISE, its correlation with established fasting indexes and its application as a prognostic marker for future dysglycemia during childhood and adolescence were assessed. We performed linear modeling and correlation analyses on a cross-sectional cohort of 2107 children and adolescents (age 5 to 18.4 years) with overweight or obesity. Furthermore, survival analyses were conducted upon a longitudinal cohort of 591 children with overweight/obesity (1712 observations) with a maximum follow-up time of nearly 20 years, targeting prediabetes/dysglycemia as the end point. The SPISE index decreased significantly with age (-0.34 units per year, p < 0.001) among children and adolescents with overweight and obesity. Sex did not have an influence on SPISE. There was a modest correlation between SPISE and established fasting markers of insulin resistance (R = -0.49 for HOMA-IR, R = -0.55 for QUICKI-IR). SPISE is a better prognostic marker for future dysglycemia (hazard ratio (HR) 3.47, 95% confidence interval (CI) 1.60-7.51, p < 0.01) than HOMA-IR and QUICKI-IR (HR 2.44, 95% CI 1.24-4.81, p < 0.05). The SPISE index is a surrogate marker for insulin resistance predicting emerging dysglycemia in children with overweight or obesity, and could, therefore, be applied to pediatric cohorts that lack direct insulin assessment.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
4.100
0.000
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords SPISE; childhood obesity; dysglycemia; early-onset diabetes; prediabetes; type 2 diabetes; insulin resistance; Hdl Cholesterol Ratio; Resistance; Glucose; Triglyceride; Adolescents; Index
Language english
Publication Year 2023
HGF-reported in Year 2023
ISSN (print) / ISBN 2218-1989
e-ISSN 2218-1989
Journal Metabolites
Quellenangaben Volume: 13, Issue: 1, Pages: , Article Number: 12 Supplement: ,
Publisher MDPI
Publishing Place St Alban-anlage 66, Ch-4052 Basel, Switzerland
Reviewing status Peer reviewed
Institute(s) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-506503-001
G-506501-001
Grants Helmholtz Institute for Metabolic, Obesity and Vascular Research of the Helmholtz Zentrum Muenchen at the University of Leipzig
joint Clinician Scientist Programme of the Medical Faculty
German Diabetes Association (DDG)
Free State of Saxony
European Regional Development Fund
Leipzig Research Center for Civilization Diseases (LIFE Child), University of Leipzig - European Union
DOI 10.3390/metabo13010100
WOS ID 000918176600001
PubMed ID 36677025
Erfassungsdatum 2024-01-16
[➜Report correction]